MRIGlobal
Programs
Integrated Health Research Services
Integrated Health Surveillance and Diagnostics - MRIGlobal performs research to counter threats to human health. In our world-class laboratories, our team supports all phases of immuno and molecular assays in our CAP/CLIA certified labs. Our capabilities range from the development of cutting-edge molecular and immunological assays focused on emerging highly infectious diseases, researching vaccines and therapeutics, and the advancement of novel, highly sensitive diagnostic assays, ushering them all through regulatory clearance.GeographiesNot indicatedDatesOct 1, 2023 – Sep 30, 2024Source990No causes providedNo populations provided–$35.1MIntegrated Defense Solutions Program
Integrated Defense Solutions - MRIGlobal guards human health and safety by defending against chemical, biological, and explosive threats. With decades of chemical warfare agent detection, evaluation, and assessment, our unique expertise and history combines scientific and engineering experts with state-of-the-art laboratory facilities to advance programs across the United States government and private sectors. This includes the design, building, testing, and evaluation of advanced products and technologies such as miniature devices capable of detecting toxic materials and chemical agents, field-deployable laboratories, and medical response systems that improve national defense and global health.GeographiesNot indicatedDatesOct 1, 2023 – Sep 30, 2024Source990No causes providedNo populations provided–$30.8MIntegrated Pharmaceutical Solutions
Integrated Pharmaceutical Solutions - MRIGlobal bridges the gap between drug discovery and commercialization. We provide the necessary services including development, manufacturing, testing, and clinical trial material management support for drug substances, drug products, intermediates, and impurities, including reference standard materials. Our team works in the appropriate regulatory framework, such as GLP, GMP, and in accordance with ICH guidelines to ensure strict compliance to quality and regulatory requirements. This work helps support informed public health decisions, and guiding investigational new drugs through development, clinical trials, and regulatory approvals.GeographiesNot indicatedDatesOct 1, 2023 – Sep 30, 2024Source990No causes providedNo populations provided–$15.3M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)